MAPT and Alzheimer disease: In the four AD participants with CSF, accounting for Aβ42, Phospho Tau, and Total Tau each CSF measure increased the beta-coefficient of CRQ by >100%, suggesting that at least in this small sample, accounting for amyloid and tau levels strengthens the relationship between CRQ and MEP Amplitude.